Bexarotene in the treatment of cutaneous T-cell lymphoma

Expert Opinion on Pharmacotherapy
Christiane QuerfeldJoan Guitart

Abstract

Primary cutaneous T-cell lymphomas encompass a spectrum of non-Hodgkin's lymphomas that are characterised by clonal proliferation of skin-homing malignant T lymphocytes. Mycosis fungoides and the leukaemic variant Sézary syndrome, collectively referred to as cutaneous T-cell lymphomas, are the most common entities. No curative therapy exists and patients ultimately develop advanced or relapsed disease that is refractory to standard treatment options. Therefore, there is a great need for the development of novel emerging therapies. Bexarotene is the first synthetic nuclear retinoid X receptor-selective retinoid approved by the FDA for the treatment of refractory cutaneous T-cell lymphoma in all stages, as both an oral capsule and a topical gel formulation. Bexarotene was found to induce apoptosis in a variety of preclinical in vitro and in vivo models including cutaneous T-cell lymphoma cells, and has shown efficacy in two multi-centre, open-label Phase II - III clinical trials for early and advanced stages of cutaneous T-cell lymphoma in patients who have failed or were refractory to standard therapies. New insights into the immunomodulatory function of bexarotene have indicated opportunities for combined treatment with IFN-alp...Continue Reading

References

Mar 1, 1989·Journal of the American Academy of Dermatology·E C VonderheidE J Van Scott
Feb 1, 1987·Archives of Dermatology·J F KesslerF L Meyskens
Jul 1, 1983·The British Journal of Dermatology·A L ClaudyJ C Le Petit
Jan 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T M KuzelS T Rosen
Jun 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A L ChengC H Wang
Jan 7, 1993·The New England Journal of Medicine·S M LippmanW K Hong
Jan 1, 1993·Acta Haematologica·B DrenoP Litoux
Dec 15, 1995·Cell·D J MangelsdorfR M Evans
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V A MillerR P Warrell
Apr 16, 1998·The Journal of Investigative Dermatology·K HanleyK R Feingold
Apr 8, 1999·The New England Journal of Medicine·S I ShermanM Duvic
Jan 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·R B ClarkS J Padula
Mar 18, 2000·The Journal of Nutrition·S M Lippman, R Lotan
Jun 1, 2000·Current Pharmaceutical Design·S Nagpal, R A Chandraratna
May 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M DuvicUNKNOWN Bexarotene Worldwide Study Group
Sep 28, 2001·The Annals of Pharmacotherapy·S F Wong
Oct 5, 2001·Skin Pharmacology and Applied Skin Physiology·C C Zouboulis
Aug 1, 2002·Leukemia & Lymphoma·Yi-Kong KeunOmar Sangueza
Oct 26, 2002·Journal of the American Academy of Dermatology·Rakhshandra TalpurMadeleine Duvic
Feb 20, 2003·Dermatology : International Journal for Clinical and Investigative Dermatology·Richard A KrathenMadeleine Duvic
Jun 24, 2003·Blood Reviews·Christiane QuerfeldSteven T Rosen
Oct 25, 2003·Journal of the American Academy of Dermatology·Peter HealdUNKNOWN Worldwide Bexarotene Study Group
Mar 23, 2004·Journal of the American Academy of Dermatology·Narin ApisarnthanaraxMadeleine Duvic
Jul 10, 2004·Journal of the American Academy of Dermatology·Christiane QuerfeldTimothy M Kuzel
Sep 25, 2004·Journal of the American Academy of Dermatology·Fiza Singh, Mark G Lebwohl
Jan 25, 2005·International Journal of Dermatology·Rokea A el-Azhary, Saskia A Bouwhuis
Feb 5, 2005·Blood·Rein WillemzeChris J L M Meijer
Mar 23, 2005·Archives of Dermatology·Jeanne B BudginAlain H Rook
Jun 2, 2005·Journal of the American Academy of Dermatology·Saskia A BouwhuisMark R Pittelkow

❮ Previous
Next ❯

Citations

Dec 19, 2007·Seminars in Oncology·Madeleine Duvic, Francine M Foss
Dec 11, 2008·The British Journal of Dermatology·N Nieto-RementeríaA Asumendi
Jan 21, 2014·Journal of the American Academy of Dermatology·Sarah I JawedChristiane Querfeld
Jul 25, 2014·ACS Medicinal Chemistry Letters·Fan ChenXiao-Kun Zhang
Nov 21, 2016·Experimental Hematology·Michelle L Churchman, Charles G Mullighan
Apr 18, 2019·American Journal of Clinical Dermatology·Robert DuffyJoya Sahu
Dec 14, 2018·Frontiers in Pharmacology·Daniel HeudoblerAlbrecht Reichle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis